Primerica reported an 8% increase in total revenues, reaching $742.8 million for Q1 2024. Net income increased by 8% to $137.9 million, and earnings per diluted share increased by 14% to $3.93. The company saw growth in its Term Life and Investment and Savings Products segments, but experienced weakness in the Senior Health business.
Life-licensed sales force increased by 5% to 142,855.
Investment and Savings Products sales increased by 20% to $2.8 billion.
Investment and Savings Products client asset values increased by 18% to $103 billion.
Earnings per diluted share (EPS) increased 14% to $3.93.
No specific forward guidance was provided in the report excerpt.
Visualization of income flow from segment revenue to net income